Patanjali didn’t mention Covid-19 drug in license application: Uttarakhand official | Latest News India - Hindustan Times
close_game
close_game

Patanjali didn’t mention Covid-19 drug in license application: Uttarakhand official

Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Meenakshi Ray
Jun 24, 2020 04:38 PM IST

The AYUSH ministry said on Tuesday that it has requested the licensing authority of Uttarakhand government to provide copies of the license and product approval details of the Ayurvedic medicines being claimed for the treatment of Covid-19.

Patanjali Ayurved Ltd, the company promoted by yoga guru Ramdev, did not mention it was developing a drug for the coronavirus disease (Covid-19) while applying for a license, an official of the Uttarakhand government said, news agency ANI reported on Wednesday.

Baba Ramdev launching a medicine kit for Covid-19, in Haridwar on Tuesday.(ANI Photo)
Baba Ramdev launching a medicine kit for Covid-19, in Haridwar on Tuesday.(ANI Photo)

Hours after Ramdev launched the drugs, the government on Tuesday sought clarification from Patanjali over its claim of having developed a cure for Covid-19 and asked it to stop advertising the product until the claim is verified.

Hindustan Times - your fastest source for breaking news! Read now.

The Centre also asked the Uttarakhand government for details of Patanjali’s new drugs—Coronil and Swasari.

ALSO WATCH | ‘Coronil and Swasari’: Ramdev’s Covid medicines available at Rs 545 for 30 days

The Uttarakhand government, which is the state licensing authority for the Haridwar-based Patanjali, approved the manufacturing and marketing for the drugs.

“As per Patanjali’s application, we issued them a license. They didn’t mention coronavirus. We only approved the license for immunity booster, cough and fever,” a licencing officer of the state’s Ayurveda department was quoted as saying by ANI.

“We will issue them a notice asking how they got permission to make the kit (for Covid-19),” the official added.

The ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) said in a statement on Tuesday that it has requested the licensing authority of Uttarakhand government to provide copies of the license and product approval details of the Ayurvedic medicines being claimed for the treatment of Covid-19.

Patanjali had claimed that the drugs have been made in association with the privately-owned National Institute of Medical Science (NIMS) in Jaipur.

It also claimed the medicines cleared a clinical trial in several cities including Delhi, Ahmedabad and Meerut and that the Randomized Clinical Trial (RCT) controlled with placebo at NIMS. However, it did not release any clinical testing data.

Earlier in the day, AYUSH minister Shripad Naik said that Patanjali’s drugs will be given a go-ahead only after the government looks into the report sent by the company.

“It’s a good thing that Baba Ramdev has given a new medicine to the country but as per rule, it has to come to AYUSH ministry first,” Naik said, according to ANI.

“They even said that they have sent a report. We’ll look into it and permission will be given after seeing the report,” Naik added.

Unveiling 'Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch Now!

Get Updates on India News, Farmers Protest Live alongwith the Latest News and Top Headlines from India and around the the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, February 22, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On